Unknown

Dataset Information

0

Prospects for Epigenetic Targeted Therapies of Bone and Soft-Tissue Sarcomas.


ABSTRACT: Targeted therapies have revolutionized cancer treatment. It is well established that alterations of chromatin configuration and modifications affect tumorigenesis of some, possibly most, bone and soft-tissue sarcomas. As epigenetic regulators play a major role in the development of bone and soft-tissue sarcomas, epigenetic drugs provide a novel potential avenue for rational targeted therapies for these aggressive cancers. The present review summarizes the application of epigenetic drugs for clinical utilization in bone and soft-tissue sarcomas and provides an overview of clinical trials currently evaluating epigenetic therapies in this space.

SUBMITTER: Wang J 

PROVIDER: S-EPMC8328687 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC3817966 | biostudies-literature
| S-EPMC3514839 | biostudies-literature
| S-EPMC6746598 | biostudies-literature
| S-EPMC4488089 | biostudies-literature
| S-EPMC6337155 | biostudies-literature
| S-EPMC3337503 | biostudies-literature
| S-EPMC4207861 | biostudies-literature
| S-EPMC5384699 | biostudies-literature
| S-EPMC2493021 | biostudies-other
| S-EPMC4344612 | biostudies-literature